Screen Shot 2017-04-03 at 9.56.02 AM
Screen Shot 2017-04-03 at 9.56.47 AM

KerraCel Ag is a Gelling Fiber Silver Dressing that uses the combination of an enhanced CMC dressing and the advanced silver technology – Ag Oxysalts™ – to create the ultimate wound healing environment

Technology

Benefits

Resources

Product & Ordering Info

The Technology

A Best-In-Class Substrate

KerraCel Ag is a 100% carboxymethyl cellulose (CMC)  gelling fiber dressing designed to help create the optimal healing environment.*

  • Quickly absorbs and locks away exudate and its harmful components3,4
  • Micro-contours to the wound bed to eliminate dead space where bacteria can live5
  • Designed to reduce the risk of periwound maceration4
  • Strong enough to be removed in one piece6

A Fast And Powerful Silver Technology

Kerracel Ag is the ONLY gelling dressing with Ag OxysaltsTM (AG3+), providing up to 6 times more power than traditional silvers (Ag1)*7:

  • Destroys biofilm and prevents re-formation8
  • Quickly kills at least 99.999% (5 log) of a broad spectrum of bacteria, including multi-drug resistant organisms9,10
kcel-ag_pad-logo

The Benefits

Three main obstacles contribute to delayed healing of chronic wounds1

Screen Shot 2017-04-12 at 11.18.48 AM
Screen Shot 2017-04-12 at 11.19.02 AM
Screen Shot 2017-04-12 at 11.16.16 AM

Biofilm is Particularly Challenging to Overcome

Biofilm  is healthcare’s invisible threat

Biofilm exists in at least 60% of all chronic wounds2

Biofilm is a community of bacteria and fungi that secretes a protective layer that firmly attaches it to the wound surface. The presence of the biofilm creates a chronic inflammatory state that prevents wound progression2

Biofilm is challenging to eliminate

It inhibits the body’s natural attempts to heal the wound and tolerates antibiotics and traditional antimicrobials2

It is difficult to fully remove—even mechanically—and can re-form within hours1,2

Screen Shot 2017-04-03 at 9.40.09 AM

An Advanced Silver Transports Healing To A Better Place

KerraCel® Ag3+ is the ONLY CMC dressing that effectively kills bacteria within a
biofilm and prevents biofilm re-formation in vitro8

Screen Shot 2017-04-12 at 11.47.15 AM
Screen Shot 2017-04-03 at 11.08.59 AM

KerraCel® Ag3+ quickly kills at least 99.999% (5 log)
of a broad spectrum of bacteria in vitro9,10,12

Screen Shot 2017-04-12 at 11.40.29 AM
Screen Shot 2017-04-12 at 11.40.38 AM

An Enhanced CMC Dressing Creates A Foundation for Healing

KerraCel® Ag3+ quickly absorbs and retains excess exudate and its harmful
components*3,4

Screen Shot 2017-04-12 at 11.42.10 AM
KCel_Verticlly_Wicks

KerraCel Ag3+ micro-contours to the wound bed to eliminate dead space where bacteria and biofilm can live and proliferate*5

Screen Shot 2017-04-03 at 9.45.26 AM

KerraCel Ag3+ Covers More*4

35%_Less

Resources

References: 1. Metcalf D, Bowler P. 2013. Biofilm delays wound healing: A review of the evidence. Burns & Trauma. ConvaTec, Inc. 2. Management of Biofilm. Wounds International. 2016. 3. Evaluation of KerraCel® Ag and Aquacel® Ag Extrasequester bacteria. CHC R543. 2017. Data on file. Crawford Healthcare Ltd. 4. In vitro fluid handling properties of KerraCel® Ag and Aquacel® Ag Extra. CHC R545. 2017. Data on file. Crawford Healthcare Ltd. 5. Zone of Inhibition evaluation of KerraCel® Ag and Aquacel® Ag Extrato uniformly kill planktonic bacteria. CHC R544. 2017. Data on file. Crawford Healthcare Ltd. 6. An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Data on file. Crawford Healthcare Ltd. 7. Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Data on file. Crawford Healthcare Ltd. 8. Evaluation of antimicrobial activity of KerraCel® Ag and Aquacel® Ag Extraagainst in vitro biofilms. CHC R541. 2017. Data on file. Crawford Healthcare Ltd. 9. Antibacterial efficacy of KerraCel® Ag and Aquacel® Ag Extraagainst planktonic species over 7 days in vitro. CHC R539. 2017. Data on file. Crawford Healthcare Ltd. 10. Rate of antibacterial efficacy of KerraCel® Ag and Aquacel® Ag Extraagainst S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Data on file. Crawford Healthcare Ltd. 11. Evaluation of antimicrobial activity of KerraCel® Ag and Aquacel® Ag Extraagainst biofilms in a porcine ex vivo model. CHC R542. 2017. Data on file. Crawford Healthcare Ltd. 12. Evaluation of antimicrobial activity of KerraCel® Ag and Aquacel® Ag Extraagainst multi-drug resistance organisms. CHC R550. 2017. Data on file. Crawford Healthcare Ltd.

PRODUCT & ORDERING INFO

ORDERING INFORMATION

If you need specific product information, or you want to know more about KerraCel Ag; Contact Us.

To place an order please contact your medical supply distributor or call 855-522-2211

Hours of Operation

Monday thru Friday 9:00AM – 6:00PM / Saturday 9:00AM – 12:00PM

Samples Order Form

Screen Shot 2017-04-03 at 11.13.52 AM